CHRO · Categories · Form 4

CHRO - SEC Form 4 insider transactions

Channel Therapeutics Corporation (CHRO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CHRO

• 336d
  SEC Form 4 filed by Director Baxter Richard B

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 4 filed by Director Greenleaf Peter

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 4 filed by Director Pauls Matthew

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 4 filed by CFO, Treas & Secty Francis Knuettel Ii

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 4 filed by Director Davis Todd C

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 4 filed by Director Friedberg Ezra M

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 336d
  SEC Form 4 filed by Director Malamut Richard

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 340d
  Director Friedberg Ezra M converted options into 80,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 340d
  Chief Financial Officer Francis Knuettel Ii converted options into 10,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 340d
  Director Davis Todd C converted options into 1,500,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 341d
  Large owner Ligand Pharmaceuticals Inc converted options into 1,500,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 419d
  SEC Form 4 filed by Director Simmons Chia-Lin

  4 - Channel Therapeutics Corp (0001919246) (Issuer)
• 419d
  SEC Form 4 filed by CEO, Pres., CFO, Treas & Secty Francis Knuettel Ii

  4 - Channel Therapeutics Corp (0001919246) (Issuer)
• 570d
  SEC Form 4 filed by Director Davis Todd C

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 570d
  SEC Form 4 filed by Director Malamut Richard

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 570d
  SEC Form 4 filed by Director Friedberg Ezra M

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 706d
  CEO, Pres., CFO Treas & Secty Francis Knuettel Ii gifted 20,000 shares, decreasing direct ownership by 4% to 515,510 units (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  Amendment: SEC Form 4 filed by CEO, Pres., CFO Treas & Secty Francis Knuettel Ii

  4/A - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  SEC Form 4 filed by Director Simmons Chia-Lin

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  SEC Form 4 filed by Chief Medical Officer Lang Eric

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  SEC Form 4 filed by Director Friedberg Ezra M

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  SEC Form 4 filed by Director Malamut Richard

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  SEC Form 4 filed by CEO, Pres., CFO Treas & Secty Francis Knuettel Ii

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 720d
  SEC Form 4 filed by Director Davis Todd C

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 836d
  Davis Todd C exercised 29,167 shares at a strike of $4.80 (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 836d
  SEC Form 4 filed by Francis Knuettel Ii

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 836d
  Friedberg Ezra M exercised 20,641 shares at a strike of $4.80 (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)

Other CHRO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends